Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness.
| Autor: | Aroor, Annayya R.1,2,3 (AUTHOR), Mummidi, Srinivas4 (AUTHOR), Lopez-Alvarenga, Juan Carlos4 (AUTHOR), Das, Nitin5 (AUTHOR), Habibi, Javad1,2,3 (AUTHOR), Jia, Guanghong1,2,3 (AUTHOR), Lastra, Guido1,2,3 (AUTHOR), Chandrasekar, Bysani3,6,7,8 (AUTHOR) chandrasekarb@health.missouri.edu, DeMarco, Vincent G.1,2,3,7,8 (AUTHOR) demarcov@missouri.edu |
|---|---|
| Zdroj: | Cardiovascular Diabetology. 4/21/2021, Vol. 20 Issue 1, p1-18. 18p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|